First approved treatment for severe orthostatic hypotension

Midodrine (Bramox) provides prescribers with a licensed treatment option for patients with severe orthostatic hypotension due to autonomic dysfunction.

by
Midodrine was previously only available as an unlicensed special product.
Midodrine was previously only available as an unlicensed special product.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package